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Abstract Verbal trait disorders encompass a wide range
of conditions and are marked by deficits in five domains
that impair a person’s ability to communicate: speech, language, reading, spelling, and writing. Nonword repetition
is a robust endophenotype for verbal trait disorders that is
sensitive to cognitive processes critical to verbal development, including auditory processing, phonological working
memory, and motor planning and programming. In the present study, we present a six-generation extended pedigree
with a history of verbal trait disorders. Using genome-wide
multipoint variance component linkage analysis of nonword repetition, we identified a region spanning chromosome 13q14–q21 with LOD = 4.45 between 52 and 55 cM,
spanning approximately 5.5 Mb on chromosome 13. This
region overlaps with SLI3, a locus implicated in reading
disability in families with a history of specific language
impairment. Our study of a large multigenerational family with verbal trait disorders further implicates the SLI3
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region in verbal trait disorders. Future studies will further
refine the specific causal genetic factors in this locus on
chromosome 13q that contribute to language traits.

Introduction
Verbal trait disorders are comorbid, developmentally associated disorders and deficits in communication. These
include clinical and subclinical disorders of speech, language, reading, spelling, and writing (Shriberg et al. 2012).
Speech sound disorders (i.e., excluding dysfluency) are the
most prevalent verbal trait disorders at preschool age, with
an estimated population prevalence of 16 % at age 4 years
(Campbell et al. 2003), decreasing to 3.8 % at age 6 years
(Shriberg et al. 1999) and 3.6 % at age 8 years (Wren et al.
2012). Deficits in speech frequently co-occur with impairments in multiple domains. For example, 11–15 % of children with speech sound disorders at age 6 also have language disorder (a neurodevelopmental disorder that can
affect both spoken or written language; Shriberg et al.
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1999). Additionally, children with speech disorders are at
higher risk for reading disability, with an estimated 18 % of
children with speech disorders and 75 % of children with
both speech and language disorders meeting criteria for
reading disability at school age (Lewis et al. 2000).
Research in the genetics of verbal trait disorders was
catalyzed by the seminal studies of the KE family, a large
extended pedigree segregating verbal dyspraxia (also
termed Childhood Apraxia of Speech; ASHA 2007; RCSLT
2011), suggesting autosomal dominant inheritance of a single gene mutation (Hurst et al. 1990). Genome-wide linkage showed a signal peak on chromosome 7q31.1 (Fisher
et al. 1998). Further fine mapping identified a point mutation in FOXP2 that resulted in a truncated protein and loss
of function in all affected individuals, but not observed in
unaffected individuals (Lai et al. 2001). FOXP2 loss of
function as a causal factor for verbal dyspraxia was further validated in unrelated individuals with severe speech
impairments similar to those in the KE family (Lai et al.
2001; MacDermot et al. 2005) and has been cross-validated
in a number of case studies (e.g., Rice et al. 2012; Shriberg
et al. 2006). Although the KE family provided an example
of a verbal trait disorder phenotype with a typical pattern of
monogenic inheritance, their story is the exception rather
than the norm. In fact, verbal trait disorders are generally
multifactorial and associated with multiple genetic and
environmental factors (Kang and Drayna 2011; Peterson
and Pennington 2015).
Due to the behavioral and cognitive heterogeneity of
verbal trait disorders, the use of endophenotypes—underlying phenotypic factors that are associated with or contribute to the manifestation of the disorder of interest because
of shared genetic factors—have been critical to the genetic
study of verbal trait disorders. One endophenotype is nonword repetition (NWR), which loads onto several cognitive processes critical for language-related ability including auditory processing, receptive language ability, and
motor planning and programming (Dollaghan and Campbell 1998). NWR tasks examine the ability to process and
temporarily store a novel series of meaningless units of
phonological information in short-term memory, and then
verbally repeat the stimuli. Such measures, which are sensitive to but not specific for any one disorder, may be more
closely influenced by genetic variation than the verbal trait
disorder itself.
NWR task performance has a strong genetic influence,
with higher concordance among monozygotic twins compared to dizygotic twins, and heritability ranging from 0.64
to 1 (Bishop et al. 1996, 2004). Furthermore, an oligogenic-trait segregation analysis of NWR in nuclear families
ascertained for reading disability estimated approximately
2.4 quantitative trait loci (Wijsman et al. 2000). A familybased linkage analysis on individuals with a family history
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of specific language impairment (SLI) identified a linkage
peak on chromosome 16q for poor performance on NWR
(SLI Consortium 2002, 2004). Follow-up family-based
and population-based association studies on NWR identified CMIP and ATP2C2 as candidates responsible for the
linkage signal (Newbury et al. 2009). CNTNAP2 on chromosome 7q35 was also associated with NWR in families
enrolled in the SLI consortium study using a candidate
gene approach after it was identified as a transcriptional
binding target of FOXP2 by chromatin immunoprecipitation (Vernes et al. 2008). In addition, CNTNAP2 was
identified by fine mapping a linkage analysis signal on
7q35 conditioned on language delay in the Autism Genetic
Resource Exchange sample (Alarcón et al. 2002, 2005,
2008). Taken together, NWR satisfies specific testable criteria for the objective identification of endophenotypes,
supporting NWR as a credible endophenotype for verbal
trait disorders (Glahn et al. 2014; Lenzenweger 2013).
With the exception of the KE family, most families with
a history of language impairment show a complex pattern
of inheritance with subtle differences in clinical presentation within the family. In the present study, we examined
an extended six-generation family with a complex pattern
of inheritance for verbal trait disorders. We chose NWR
in this analysis because (1) it is a robust endophenotype
for verbal trait disorders (i.e., speech sound disorder, language disorder, and developmental dyslexia); (2) is highly
heritable; (3) has a Mendelian model of inheritance (in
at least one study; Wijsman et al. 2000); and (4) is stable
throughout an individual’s lifetime, even in those who are
language recovered following impairment in childhood
(Bishop et al. 1996; Shriberg et al. 2009). The latter attribute of NWR tasks is particularly important because subjects within this family range in age from 3 to 95 years,
requiring a phenotype that can be ascertained and compared across all age groups. The present analysis provides
strong support for chromosome 13q14–q21 as a locus that
contributes to poor performance on NWR in this extended
pedigree.

Methods and materials
Ascertainment
We studied 62 individuals from a six-generation 90-member family of European ancestry with a history of verbal
trait disorders. The family was ascertained with the assistance of a family member. The 62 family members assessed
included 35 females and 27 males ranging in age from 3 to
95 years. There is no evidence of consanguinity based on
genealogy or unexpected high kinship coefficients within
the pedigree.
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Written informed consent was approved by the University of Wisconsin-Madison Institutional Review Board
(IRB). All subjects were assessed by one of two experienced examiners in the participants’ homes or hotel sites in
five states within the continental US. All oral instructions
and audio-recorded stimuli were presented at comfortable
listening levels based on findings from a conventional hearing screening. The assessment protocol included the following measures and instruments: Kaufman Brief Intelligence Test-2 (Kaufman and Kaufman 2004; nonverbal and
verbal IQ), Nonword Repetition Task (NRT; Dollaghan and
Campbell 1998), Syllable Repetition Task (SRT; Shriberg
et al. 2009), Goldman-Fristoe Test of Articulation-2 (Goldman and Fristoe 2000; speech), Clinical Evaluation of Language Fundamentals-Preschool-2 (Wiig et al. 2004; language), Clinical Evaluation of Language Fundamentals-4
Screening Test (Semel et al. 2004; language), Woodcock–
Johnson Tests of Achievement, 3rd edition (Woodcock
et al. 2001; reading, spelling, and writing), and questionnaires for parent-reporting or self-reporting medical and
special educational histories and concerns. One individual
had a composite IQ <75, but performance on the NWR
tasks was unimpaired. To maximize genetic informativeness, this individual’s NWR scores were retained for the
analysis. All other individuals had an IQ between 84 and
126.
Phenotype
The NRT is a NWR task that consists of 16 nonwords.
To reduce the articulatory burden, the NRT does not contain the most phonetically complex consonants (the “late8” consonants; Shriberg 1993; Dollaghan and Campbell
1998). Nonwords ranged in length from one to four syllables (four each) with the shortest nonwords presented first
and the longest last. Each repeated consonant and vowel/
diphthong (totaling 20 different phonemes) was later transcribed as correct or incorrect by two research speech
pathologists. NRT scores were calculated by dividing the
total phonemes correctly repeated by the total phoneme targets. Ratios were then converted to age–sex standardized
scores for downstream analyses using a reference database
of 200 typical speakers, ages 3–80 years (Potter et al. 2012;
Scheer-Cohen et al. 2013) that included descriptive statistics for NRT and SRT scores.
The SRT is another NWR task comprised of 18 nonwords that include only four of the “early-8” consonants
(/b/,/d/,/m/, and/n/) and the vowel/ɑ/(Shriberg 1993). This
NWR task was designed to accommodate individuals who
have incomplete phonetic inventories and/or articulatory
impairments. Items range in length from two to four syllables with the shortest presented first and the longest last.
The consonant responses to each recorded syllable were

1331

transcribed as correct or incorrect. The number of correctly
repeated consonants was divided by the total number of target consonants. The ratio was then converted to a standard
score using the reference database.
Studies of speech-language disorders using the NRT
have supported its validity and reliability (e.g., Archibald
and Gathercole 2006; Moore et al. 2010), including a reference sample of 95 children with typical speech and 63
children with speech delay, described in a technical report
on the NRT and SRT (Shriberg and Lohmeier 2008). Findings from this reference sample include psychometric data
supporting the distributional characteristics of scores for
parametric statistical analyses, and analyses supporting the
construct validity, concurrent validity, interjudge transcription reliability, and internal reliabilities of both tasks.
In the present study, point-to-point percentage of agreement estimates ranged from 75.6 to 88 % across nonword
task and phoneme class; other validity and reliability estimates were generally in the 0.70–0.85 range. The Pearson
r coefficient between standardized scores on the two nonword tasks in the present data was 0.66, consistent with
the coefficient of 0.73 reported in Shriberg and Lohmeier
(2008). Thus, consistent with discussion elsewhere, there
is only moderate collinearity between the two measures of
NWR (Shriberg et al. 2009).
Sensitivity and specificity for identifying speech and
language disorders using the SRT were further supported
by a second reference sample of 550 speakers, including
speakers with typical speech and typical language, speech
delay and typical language, language impairment and typical speech, and speech delay and language impairment
(Lohmeier and Shriberg 2011). Additional construct validity support for the SRT was presented in Shriberg et al.
(2009), followed by a series describing SRT procedures
to explicate encoding, memorial, and transcoding processes underlying performance on nonword imitation tasks
(Shriberg et al. 2012).
Because there is no battery of speech, language, reading,
spelling, and writing tests appropriate for the lifespan ages
of the present extended family, we used standardized scores
from either the NRT or SRT to assign a categorical phenotype. Verbal trait impaired (Verbal Trait+) was defined as
performing greater than one standard deviation below the
mean on either the NRT or SRT. Preliminary studies indicated that a cutoff below one standard deviation on either
the NRT or the SRT was maximally sensitive and specific
to subjects with only mild, subclinical difficulty in one or
more of the five verbal traits based on parent- and selfreported histories of children and adults. Of the 41.9 % of
participants in the present study who met the nonword criteria for a verbal trait disorder (see Table 1), 19.2 % met
criteria on the NRT only, 23.1 % met criteria on the SRT
only, and 57.7 % met criteria on both nonword tasks.
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Table 1  Percentagesa of affected (Verbal Trait+) and not affected (Verbal Trait−) participants in an extended family of 62 members and tests of
two proportions results for each variable. Participant age was divided into four lifespan cohorts
Variable

Participants
Gender
Female
Male
Age
Preschool (3–5)
School age (6–18)
Adult (19–64)
Senior (65–84)
Verbal trait history
Speech
Language
Reading
Spelling
Writing
Participants scoring more than one
SD below the mean in one or
more verbal trait domains

Total n

Verbal trait+
(VT+)

Verbal trait−
(VT−)

Tests of two proportionsb

n

%

n

%

Z

p

Confidence interval

62

26

41.9

36

58.1

−1.82

0.069

−0.335, 0.012

35
27

11
15

31.4
55.6

24
12

68.6
44.4

−3.35
0.82

0.001
0.411

−0.589, −0.154
−0.154, 0.376

3
21
30
8

1
7
14
4

33.3
33.3
46.7
50.0

2
14
16
4

66.7
66.7
53.3
50.0

−0.87
−2.29
−0.52
0.00

0.386
0.022
0.605
1.000

−1.000, 0.421
−0.618, −0.048
−0.319, 0.186
−0.490, 0.490

15
17
24
18
3

11
8
13
10
1

73.3
47.1
54.2
55.6
33.3

4
9
11
8
2

26.7
52.9
45.8
44.4
66.7

0.004
0.731
0.562
0.502
0.386

37

19

73.1

18

50.0

2.89
−0.34
0.58
0.67
−0.87

0.150, 0.783
−0.394, 0.277
−0.199, 0.365
−0.214, 0.436
−1.000, 0.421

1.92

0.055

Sig.c

*

*

*

−0.005, 0.469

a

The row-wise percentages use the Total n in the second column as the denominator. The denominators for each percentage in the last row are
26 and 36, respectively
b
c

Minitab 17 Statistical Software (2010). [Computer software]. State College, PA: Minitab, Inc. (www.minitab.com)
* p < 0.05

Participants
Tables 1, 2 describe demographic and phenotype variables for participants meeting NWR task criteria for
affected (Verbal Trait+; VT+) and not affected (Verbal Trait−; VT−), including tests for significant differences between the proportions of each classification.
The difference in the percentages of VT+ (41.9 %) compared to VT− (58.1 %) participants was non-significant
(Z = −1.82). Significantly fewer females met criteria for
VT+ (31.4 %) than VT− (68.6 %; Z = −3.35), but the
proportion of males who met criteria for VT+ (55.6 %)
compared to the proportion who met criteria for VT−
(44.4 %) was non-significant (Z = 0.82). Among the four
age groups, the only age group within which affection
status differed significantly was the school-aged participants, who had a significantly lower percentage of participants who met criteria for VT+ (33.3 %) than VT−
(66.7 %; Z = −2.29).
Last, Verbal Trait History for problems in verbal trait
domains of speech, language, reading, spelling, and/or writing were determined by test scores in any of the relevant
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Table 2  Descriptives for VT+ and VT− individuals in the family
across the syllable repetition and nonword repetition tasks
Verbal trait+ (VT+)
SRT
Mean (SD)
Skewness
Kurtosis
NRT
Mean (SD)
Skewness
Kurtosis

Verbal trait− (VT−)

−3.01 (3)
−0.96
−0.05

0.27 (0.7)
0.25
0.53

−2.07 (1.67)
−0.22

0.42 (0.86)
0.04

−0.16

−0.77

domains lower than one standard deviation below standardized means, or any self- or parent-reported difficulty in
any of the five domains (Supplemental Table 1). Of the Verbal Trait History variables in Table 1, only one verbal trait
domain was associated with significant between group proportions. A significantly greater percentage of participants
with test scores, self-reported, or parental-reported histories
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of speech disorders met the nonword criterion for VT+
(73.3 %) compared to the percentage who met criterion
for VT− (26.7 %; Z = 2.89). Using conventional criteria
for statistical significance, the percentage of VT+ participants who had at least one test score or questionnaire entry
indicating a concern with any one of the five verbal traits
(73.1 %) was not significantly larger than the percentage
of VT− participants with such histories (50.0 %; Z = 1.92;
p = 0.055; CI −0.005, 0.469).
DNA collection and genotyping
DNA was extracted from whole blood using the Gentra
Puregene Blood Kit (Qiagen) at the University of Nebraska
Medical Center. Genotyping across 551,839 single nucleotide polymorphism (SNP) markers was performed using
the Illumina Infinium HumanCoreExome-24-v.1 at the Yale
Center for Genome Analysis (Orange, CT). Genotypes
were called using Illumina GenomeStudio with a total of
547,644 (99.24 %) passing quality control (QC). One individual failed QC due to low genotyping call rate and was
excluded from the analysis.
PBAP: marker sub‑selection, pedigree structure
validation, and IBD computation for linkage analysis
Reference map files for the HumanCoreExome dense
marker panel were obtained from the Rutgers maps (Matise et al. 2007), with integrated linkage-physical maps in
sex averaged Haldane genetic distances (cM). Reference
genotype data for Europeans were extracted from the main
European (EUR) population data from the 1000 genomes
project (The 1000 Genomes Project Consortium 2010) to
determine linkage disequilibrium (LD) and minor allele frequencies (MAF) between markers for marker sub-selection.
We used the pedigree based analysis pipeline (PBAP)
to sub-select genetic markers for pedigree quality control (QC) and for interfacing with MORGAN (Thompson
2011) to calculate inheritance vectors (IV) used for linkage analysis (Nato et al. 2015). Use of MORGAN allowed
multipoint analysis on the complete pedigree. Generation
of genome-wide SNP marker sub-panels from the dense
marker panel was conducted to (1) reduce LD between
markers and minimize type 1 error, (2) reduce computational time (while maximizing genotypic informativeness
within the pedigree), and (3) perform QC on pedigree
structure (i.e., parent–offspring swaps). PBAP marker subselection and pedigree structure validation are described in
detail elsewhere (Nato et al. 2015). Briefly, three non-overlapping marker sub-panels from the original dense marker
panel (Illumina HumanCoreExome-24-v.1) were generated based on the following criteria: (1) maximum LD (r2)
threshold equal to 0.04 in the EUR reference population;
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(2) MAF 0.2–0.5 in the EUR reference population; (3)
non-monomorphic marker within the pedigree;( 4) minimum intermarker distance of 0.5 cM; and (5) restricted to
the 22 autosomes. A separate marker sub-panel was generated for pedigree structure validation using similar criteria
as above except maximum LD threshold was equal to 0.25
and MAF from 0.3 to 0.5 in the EUR reference population.
For genome-wide linkage analysis (excluding sex chromosomes), a total of 5448, 5493, and 5498 markers for subpanels 1, 2, and 3, respectively, were created. A sub-panel
of 5454 genome-wide markers was created for pedigree
structure validation.
QC for appropriate parent–offspring relationships within
the larger pedigree was assessed by comparing expected
kinship coefficients (based on pedigree structure) and estimated coefficients computed by maximizing the likelihood from available genotype data across the 5454 marker
sub-panel (Choi et al. 2009). Individual relationship pairs
were flagged if the estimated kinship coefficient fell outside a 99.5 % confidence interval from expected. No sample swaps or incorrect parent–offspring relationships were
observed within the larger pedigree.
From each marker sub-panel created for linkage analysis, PBAP prepared data files to generate IVs that described
the flow of genetic information through a pedigree for an
individual using gl_auto in the MORGAN suite of programs (Thompson 2011). The gl_auto program uses a
combination of exact and Markov Chain Monte Carlo
(MCMC) based estimations to sample IVs for each individual. For the current analysis, IVs were sampled for each
marker subpanel using the following parameters: 15,000
MCMC burn-in iterations, sampling by scan and 100,000
MCMC iterations with progress checked every 20,000
iterations (L-Sampler = 0.2), saving 2000 realizations for
IV sampling. Sampled IVs were then converted to Sequential Oligonucleotide Linkage Analysis Routines (SOLAR)
(Almasy and Blangero 1998) compatible multipoint identity-by-descent (MIBD) matrices using custom scripts
written by the Wijsman lab, and imported into SOLAR for
downstream linkage analysis.
Statistical analysis
All statistical analyses were conducted using the SOLAR
software package (version 7.3.9; Almasy and Blangero
1998). SOLAR utilizes a maximum likelihood variance decomposition approach to estimate the influence of
genetic and environmental effects on a phenotypic trait by
modeling the covariance among family members relative to
genetic kinship (identity by descent). A liability threshold
model was used to handle discrete traits under the assumption that the affection status of an individual was determined by their underlying genetic risk exceeding a certain
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threshold for the phenotype (i.e., VT+; Duggirala et al.
1997). Using maximum likelihood techniques, initial models were screened for the covariate effects of age, age2, sex,
age × sex, age2 × sex, and IQ. After covariate screening
non-significant covariates (p > 0.1) were removed from the
final model. In addition, a variance component for household random effects that further controlled for shared environment among nuclear families within the larger pedigree
was included. The final model representing the log likelihood when the additive genetic variance was equal to 0 (no
linkage elements) and covarying for household and age*sex
effects, was used as the null model for hypothesis testing
during linkage analysis.
Genome-wide multipoint variance component linkage analyses were conducted to examine linkage between
VT+ and MIBDs. Multipoint linkage analysis considers
recombination along a chromosome to determine the probability that a trait locus is located within a genomic region.
Maximum likelihood estimates for linkage were calculated
at approximately 0.5 cM intervals across the 22 autosomes
and compared against the null model (no linkage) using a
likelihood ratio test (df = 1).
Empirical p values were computed using a simulation
that generated a distribution of LOD scores under a null
model of no linkage. 1,000,000 simulations were conducted, each generating a random informative marker that
was tested for linkage with VT+ status. This distribution
of observed LOD scores in the simulation was then used
to determine the empirical p value of the experimentally
observed LOD scores.
Haplotypes were assigned using MERLIN (Abecasis et al. 2002). The large pedigree exceeded the bit limit
MERLIN could handle, thus the family was split into six
smaller subpedigrees for haplotype assignment and then
manually reconfigured to confirm consistency of haplotypes called across the lineages. Five of the six subpedigrees were assigned based on distinct sublineages that
originated from Generation II, and included all individuals
within the last four generations (Generations III–VI) of the
family. The sixth subpedigree consisted of all individuals in
the first two generations (Generations I and II) and select
individuals in Generations III and IV to confirm the transmission of the haplotypes observed in the aforementioned
five subpedigrees.

Results
Genome-wide multipoint linkage analyses for VT+ revealed
a peak LOD score of 4.35 (empirical p value <1 × 10−6)
between 52 and 55 cM on chromosome 13q14.2–q14.3
(Fig. 1 and Supplemental Table 2) with marker subpanel 1.
This region spans base pair positions 48–53.5 Mb across 5
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linkage (SNP) markers on chromosome 13, encoding a total
of 41 genes (build GRCh37/hg19). To determine whether
the linkage signal was due to an effect of pseudorandom
marker sub sampling, multipoint analyses on chromosome
13 were conducted again using non-overlapping marker
subpanels 2 and 3, which were generated at the same time
as marker subpanel 1 in PBAP. Findings were recapitulated
with peak LOD scores of 4.24 and 3.96 using marker subpanels 2 and 3, respectively, again spanning the same region
of chromosome 13q14.2–14.3 (Supplemental Table 3). Of
the 41 genes within base pair positions 48–53.5 Mb, 26
genes show moderate expression in the developing brain
(BrainSpan 2011), but only 8 have known neurological or
cognitive function (Carrozzo et al. 2007; de Bie et al. 2007;
Dening et al. 1989; Elpeleg et al. 2005; Hilschmann et al.
2002; Jaberi et al. 2013; Kind et al. 2014; La Piana et al.
2016; Maas et al. 2015; Morris et al. 2012; Ocklenburg et al.
2015; Ostergaard et al. 2007; Rice et al. 2007; Spiechowicz et al. 2006; Vidal et al. 1999, 2000; Wei and Hemmings
2005; Xu et al. 2010; Yamagata et al. 1999; Yasuda et al.
2007; Zhang et al. 2006; Supplemental Table 4). When
considering LOD scores greater than 3 (empirical p value
<0.0002), the linkage signal expands to 46–61 cM across 22
linkage markers spanning a 23.2 Mb region on chromosome
13q14.11-21.32, encompassing approximately 77 genes.
Estimation of haplotypes in the extended family provides evidence of at least 3 distinct haplotypes on chromosome 13 segregating with VT+ (Fig. 2). A recombination in Haplotype 1 (Haplotype 1-recombined) in affected
individual 3 between SNPs rs7337528 and rs2981 defines
the centromeric boundary of LOD = 4.35 at 52 cM
(Figs. 2, 3). This particular segment of Haplotype 1,
defined by alleles shared IBD at rs2981, rs2812219,
rs6561602, and rs997687 (52.92–55.06 cM), segregates
with the phenotype in the lineage originated by a founder
in the oldest generation. For the remaining information,
data are presented without a conventional haplotype pedigree graphic to preserve anonymity of the family. Haplotype 2 originates from a married-in founder in Generation
II and segregates to two siblings in Generation III, four
descendants in Generation IV and four descendants in
Generation V. Seven of ten descendants with Haplotype
2 are VT+. Last, Haplotype 3 originates from a marriedin founder in Generation III, segregates to two siblings in
generation IV, and four descendants in Generation V. Six
of seven pedigree members with Haplotype 3 are VT+.
There are no recombinations within Haplotypes 2 or 3
that would define the broader shoulders of the linkage
signal from 45 to 62 cM (Fig. 3). Overall, the presence
of at least three distinct haplotypes that cosegregate with
VT+—including married-in Haplotypes 2 and 3—implicate multiple contributing variants segregating through
this family.
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Fig. 1  Multipoint linkage results conditioned on impaired NWR at chromosome 13. Genes and associated SNPs under the highest linkage peak
of LOD = 4.35, between 52 and 55 cM spanning physical positions 48–53.5 Mb on reference genome assembly build GRCh37/hg19
Fig. 2  Haplotypes spanning
genomic location 45–62 cM
on chromosome 13 segregating
with Verbal Trait+ (affected)
status in the family. The centromeric and telomeric boundaries
of Haplotype 1-Recombined
are defined by a recombinatorial events within individual 3
(Fig. 3). No recombinatorial
events in the family offer clear
centromeric and telomeric
boundaries for Haplotypes 2
and 3
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Fig. 3  Haplotype assignments spanning genomic location 45–62 cM
on chromosome 13. The pedigree depicted is truncated to reflect the
recombinatorial event observed in affected individual 3 that outlines

the centromeric and telomeric border of the linkage signal spanning
52–55 cM. Affected individuals are black diamonds, while unaffected
individuals are gray diamonds

Other suggestive linkage signals (LOD >1.5; empirical p
value <0.01) were observed on chromosome 2q37.1, 4q12–
13.2, 4q25, 7q22.3–31.2, 8q24.3, and 12p13.33 (Supplemental Table 2). Most notably, the linkage peak spanning
7q22.3–q31.2 has a max LOD = 2.06 and contains the
gene FOXP2—a causal gene for Childhood Apraxia of
Speech (Fisher et al. 1998; Lai et al. 2001).

Discussion
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The present study identified a linkage signal spanning
chromosome 13q14–q21 using a categorical phenotype
(VT+ or VT−) derived from performance on NWR in an
extended pedigree with a history of verbal trait disorders.
This region encompasses SLI3 on chromosome 13q21,
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a SLI locus previously identified by Bartlett et al. (2002),
using a family-based linkage analysis in five Canadian
families of Celtic ancestry with a history of specific language impairment (SLI). Their analysis was conditioned on
a categorical reading-IQ discrepancy phenotype (nonword
reading score at least one standard deviation below performance IQ), which they replicated in a larger independent
US sample using the same phenotype (Bartlett et al. 2004).
This region has also been implicated in autism spectrum
disorder (ASD), a neurodevelopmental disorder with a core
language component in combination with other core abnormalities in social and repetitive behaviors. A linkage signal
at chromosome 13q21 was observed with a language delay
phenotype in the Collaborative Linkage Study of Autism
(CLSA; Bradford et al. 2001). Furthermore, deletions at
13q12 through 13q21 have been reported in three subjects
with ASD and poor receptive and expressive vocabulary
(but normal speech), and in a subject with ASD with auditory processing deficits (Mitter et al. 2011; Smith et al.
2002; Steele et al. 2001). These deleted segments partially
overlap the linkage peak in our present study, where LOD
>1.5 (Supplemental Tables 2 and 3). The convergence of
these findings associated with 13q14–q21 with related language phenotypes that underlie verbal trait disorders provides compelling support for this locus.
Within this pedigree, there are at least three distinct haplotypes segregating with VT+, of which, only Haplotype
1 originated with a founder in the oldest generation—the
other two are more recently married into, consistent with
assortative mating. Within the EUR reference population of
1000 genomes project, Haplotype 1-Recombined (Fig. 2) is
common with a frequency of 0.046. In a clinical context,
verbal trait disorders such as developmental dyslexia and
specific language impairment (SLI) have a high prevalence
in the United States. The prevalence of developmental dyslexia is 7 % in the general population, and the prevalence of
specific language impairment (SLI) is 5–8 % among preschool children (Peterson and Pennington 2015; Tomblin
et al. 1997). Different haplotypes segregating within the
family could indicate a single gene with different causal
variants segregating within the family. It is also possible
that different genes at the same locus, or at different loci,
are mediating NWR performance. Further fine mapping
and sequencing of the region is necessary to disentangle
these possibilities and elucidate the potential variants driving the signal observed in the present study.
Underneath the peak linkage signal spanning the
52–55 cM region of chromosome 13 with LOD >4, there
are interesting gene candidates with known function in
neuropsychiatric disorders and neurodevelopment. ITM2B
encodes a transmembrane protein that helps to inhibit the
accumulation of beta-amyloid, but mutations have been
implicated in Familial British Dementia and Familial

1337

Danish Dementia with similar pathology to Alzheimer
disease (Vidal et al. 1999, 2000). Setdb2, the zebrafish
ortholog of SETDB2, is known to regulate left–right asymmetry in the zebrafish central nervous system (Xu et al.
2010). Human epidemiological research has also associated
SETDB2 with handedness (left versus right preference)
with specific variants linked to reduction in laterality (Ocklenburg et al. 2015). This provides an interesting parallel
to previous evidence that suggests language and reading
disability are linked to atypical cerebral laterality (asymmetry) since language-related behavior is typically left
lateralized (Leonard and Eckert 2008; Scerri et al. 2011).
However, it is important to note that SETDB2 has not yet
been directly implicated in reading or language disability.
ATP7B is a known gene associated with Wilson disease,
which is a disorder characterized by the deposition of copper in the liver, brain, and other tissues, leading to neurological and cognitive deterioration including memory loss,
tremors, and emotional changes (de Bie et al. 2007; Dening Tr 1989). PCDH8 is part of the protocadherin family
of CNS-specific cell adhesion molecules that plays a role
in the development of neural circuitry (Hilschmann et al.
2002; Yamagata et al. 1999). Interestingly, the rat ortholog
of PCDH8, Arcadlin, has been implicated in synaptic function and is dynamically expressed upon activation of hippocampal circuitry—a neural network necessary for learning and memory (Yasuda et al. 2007).
By examining the extended linkage peak spanning
45–62 cM with LOD scores >3, we identified another
three genes in the protocadherin family located telemetric
to PCDH8—PCDH17, PCDH20, and PCDH—each of
which encodes cell–cell adhesion molecules that are primarily expressed in the brain (Kim et al. 2010). Variation in
PCDH9 has been linked to ASD and SLI, while PCDH17
is highly expressed in the prefrontal and anterior regions
of the temporal cortex and subcortical structures such as
the thalamus, ventral striatum, and anterior cingulate—an
expression pattern highlighting an overlap with corticostriatothalamic circuitry critical for higher order cognitive
function and language development (Abrahams et al. 2007;
Marshall et al. 2008).
Our linkage findings on chromosome 13q do not correspond to other genome-wide linkage scans conditioned on
NWR. A family-based linkage analysis conducted by the
SLI consortium localized to chromosome 16q with further
fine mapping identifying CMIP and ATP2C2 as potential
gene candidates mediating NWR in their sample (SLI Consortium 2002, 2004; Newbury et al. 2009). Another study
performed by Brkanac et al. (2008), observed linkage signals on chromosomes 4p12, 12p, and 17q in families with
a history of dyslexia. Discrepancies in genomic regions
associated with NWR, in part, may be due to differences
in the particular NWR test used to evaluate respective
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subjects. Although the measures used in these studies do
ostensibly assess NWR, there are differences in each that
may more heavily tap into different combinations of underlying cognitive and/or behavioral abilities, such as phonological working memory, long-term lexical knowledge, and
articulatory difficulty with nonsense words (Estes et al.
2007; Gathercole 1995). Ascertainment differences and
differences in age ranges between the present study and
others could also contribute to the observed discrepancies.
The SLI consortium used a family-based linkage analysis
examining 186 nuclear families affected with SLI (SLI
Consortium 2002, 2004). Brkanac et al. (2008), used a family-based design examining 144 families with a history of
dyslexia, whereas the present study examined one extended
family with verbal trait disorder that could be derived from
one or more rare variants. The small number of subjects in
each of these studies would significantly limit the power
to detect rare and uncommon variants. Ultimately, these
findings may also reflect locus heterogeneity and highlight
different molecular and biological mechanisms associated
with NWR.
Due to the complex inheritance pattern of impaired
NWR performance, a nonparametric analysis using variance components was used so that pre-specified values
for parameters defining the genetic model would not be
required (Bailey-Wilson 2004). This is in contrast to a
parametric analysis that requires the specification of a
genetic model, with the concern that a poorly specified
model could lead to suboptimal results. An advantage to
using a variance components approach is that it tends to
be more powerful relative to other trait mapping methods (Kleensang et al. 2010). However, a limitation is that
variance components provides poorer localization of the
trait locus compared to a parametric analysis, and generally requires additional fine mapping to isolate the region
(Amos and de Andrade 2001; Williams et al. 1997). An
additional limitation is that we used a composite variable across two different NWR tests—performing more
than one standard deviation below the age–sex standardized mean on either the NRT or SRT—to derive VT+
or − status. Although both measures evaluate NWR, the
individual test items differ. As described previously, the
SRT focuses on the repetition of syllables that comprise
only four “early-8” consonants and can be used to examine NWR ability in young children and speakers of any
age with limited phonetic inventories or speech sound
disorder (Shriberg et al. 2009). In comparison, although
the NRT was designed to exclude late developing English
consonants (the ‘late-8’), younger children and speakers
of any age with speech sound disorder can have articulation errors repeating the 9 different vowels and diphthongs, and 11 different consonants in the nonsense
words, thus confounding test performance and reducing
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transcription reliability (Shriberg et al. 2009). Because
individuals tested in the extended pedigree ranged in age
from 3 to 95 years old, it would not be optimal to test all
individuals on only the NRT or SRT, as they may differ
in their sensitivity to persistent types and levels of NWR
deficits across the lifespan.
In conclusion, we found a statistically significant
genome-wide multipoint linkage signal on chromosome
13q14–q21 using a NWR phenotype in an extended pedigree with a family history of verbal trait disorder. We
hypothesize that the region of 13q14–q21 is a susceptibility
locus for verbal trait disorders, but additional work must be
conducted to (1) identify the gene(s) in this region contributing to the linkage signals observed in the present study
and others that have been identified this same region, and
(2) elucidate the complex genetic and environmental interactions that may increase susceptibility.
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